|Day's range||10.25 - 10.32|
|52-week range||7.15 - 10.43|
|PE ratio (TTM)||45.13|
|Dividend & yield||0.03 (0.42%)|
|1y target est||7.69|
LAS VEGAS, Jan. 6, 2017 /PRNewswire/ -- The world is about to find out how well it really sleeps - and how to sleep better - thanks to SleepScore Labs, a new company focused on helping people understand ...
- World's largest repository of sleep data - a giant step forward for sleep medicine - Predictive analytics from data will improve therapy and outcomes for sleep patients - Milestone reinforces ResMed's ...
SAN DIEGO, Dec. 20, 2016 /PRNewswire/ -- ResMed (NYSE: RMD) today announced that industry leader Carlos M. Nunez, MD, will become ResMed's chief medical officer, effective January 3, 2017. Nunez most recently ...